Premium
Private Equity major Chrys Capital, and its limited partners, have entered the fray to acquire Medley Pharmaceuticals, three people aware of the development said. Strategic bidders, such as Cipla and Torrent Pharma, are also in the race to buy the business. Chrys Capital may receive the backing of limited partner Ontario ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
